130A Veritas In Silico
- 828
- -19-2.24%
Veritas In Silico News
Veritas In Silico: Fiscal Year Ending December 2024, 3rd Quarter, Financial Results
Veritas In Silico: Organizational Reforms and Personnel Changes of General Managers
Veritas In Silico: Notice regarding organizational reforms and personnel changes (department manager level)
Veritas In Silico: Non-consolidated Financial Results for the Nine Months Ended September 30, 2024 [Under Japanese GAAP]
Veritas In Silico: Mitsubishi Gas Chemical and Veritas In Silico, Sign MOU on Joint Business of Research and Development of RNA-Targeted Drugs
Veritas In Silico: Mitsubishi Gas Chemical and Veritas In Silico sign MOU for joint venture to develop pharmaceuticals targeting RNA
Veritas In Silico: Liverpool ChiroChem and Veritas In Silico Agree to Form a Strategic Partnership of mRNA-Targeted Drug Discovery and Development
Veritas In Silico: Notice of partnership agreement with Liverpool Chirochem in the UK regarding joint drug discovery business for small molecule drugs targeting mRNA
Veritas In Silico: Notification regarding Achievement of Milestone in Joint Drug Discovery Research with Shionogi & Co., Ltd.
Veritas In Silico: Notice of milestone achievement due to progress in joint drug discovery research with Shionogi Pharmaceutical Co., Ltd.
Veritas In Silico: [Delayed] Interim Financial Results - FY2024 1H
Veritas In Silico: Unconsolidated financial statements for the six-month period ending June 30, 2024 [based on Japanese accounting standards]
Veritas In Silico: Announcements of individual stocks regarding the achievement of milestones for joint drug discovery research with Takeda Pharmaceuticals sp adr.
Veritas In Silico: Notice regarding changes in officers
Veritas In Silico: Notice regarding a decrease in the amount of capital (capital reduction)
Veritas In Silico: Independent Officer Notification Form
Veritas In Silico: Articles of Incorporation 2023/08/18
Veritas In Silico: Notice Concerning Changes in Major Shareholders
Veritas In Silico: Matters relating to business plans and growth potential
Veritas In Silico: Notice of our financial results information etc. associated with listing on the Tokyo Stock Exchange Growth Market
Analysis
Price Target
No Data
No Data